Compounds, pharmaceutical compositions, kits and methods useful for inhibiting HDAC, thereby treating a disease state for which HDAC possess activity that contributes to the pathology and/or symptomology of the disease state. The compound is selected from the group consisting of: ##STR00001## wherein the variables are as defined herein.

 
Web www.patentalert.com

< Oxazolidinone nicotinic acetylcholine receptor agonists

> Compounds for the treatment of hepatitis C

> Indane compounds

~ 00578